Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Biliary Radiofrequency Ablation of Malignant Bile Duct Obstruction

NCT02582541 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.

NCT NCT02582541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02582541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Biliary Radiofrequency Ablation of Malignant Bile Duct Obstruction
Lead sponsor
The Second Hospital of Nanjing Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2014
Completion date
November 30, 2018
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct obstruction, cholangiocarcinoma